Skip to content
Noble Life Sciences Logo Noble Life Sciences Logo Noble Life Sciences Logo
  • Home
  • Drugs
    • Oncology
    • Infectious Diseases
    • Preclinical Vaccine Development
    • Custom Animal Models
  • Devices
    • Cardiovascular
    • Orthopedics
    • Trauma
    • Wound Healing
  • Toxicology
  • Custom Antibody
  • Services & Products
    • Blood & Tissue Products
    • Research Animals
    • Colony Management
    • Analytical & Laboratory Services
    • Imaging Capabilities
    • Specialty Services
    • Biomarker Research Services
      • Biomarker Discovery & Validation
      • Molecular Tumor Profiling
      • Clinical Biomarker Development and Implementation
  • Resources
  • About
    • Mission
    • Management Team
    • News
    • Blog
    • Facilities
    • Careers
  • Contact
Previous Next
Tech Council OF Maryland Interviews Srujana Cherukuri

TECH COUNCIL OF MARYLAND INTERVIEWS SRUJANA CHERUKURI

The Tech Council of Maryland recently interviewed Srujana Cherukuri, Vice President and Chief Operations Officer of Noble Life Sciences. Click here to view the full article.

Noble Life Sciences2018-04-23T15:24:32+00:00December 15th, 2016|News|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditGoogle+TumblrPinterestEmail

Recent Posts

  • Preclinical Models in CAR T-cell Therapy: Promising new approach to study tumor clearance by CAR T-cells
  • Isolated Heart Stand: Applications In Ex Vivo Cardiovascular Drug And Device Testing
  • An Overview of Inhalation Drug Delivery Services: Collaboration with Pneumodose
  • Evaluating Agents for the Treatment of Sepsis Using Infectious Disease Models
  • TCGA Publishes Highly Anticipated Results on Tumor Sequencing

Archives

  • January 2019
  • October 2018
  • May 2018
  • April 2018
  • February 2018
  • January 2018
  • July 2017
  • April 2017
  • December 2016
  • February 2016
  • December 2014
  • April 2014
  • January 2014
  • December 2013
  • October 2013
  • April 2013

Categories

  • Blog
  • News
Copyright © 2018 Noble Life Sciences, Inc. All Rights Reserved.